Pro Medicus Limited has disclosed a comprehensive corporate governance framework, including the adoption of a diversity policy, a code of conduct, a whistleblower policy, and an anti-bribery and corruption policy. The company also detailed its governance structure, including the existence of a combined Audit and Risk Management Committee and a Remuneration Committee, and provided information on the evaluation of board performance and the disclosure of board skills.
Material actions and disclosures
Pro Medicus Limited has adopted a diversity policy and disclosed measurable objectives for achieving gender diversity. The company has also disclosed a code of conduct for directors, senior executives, and employees, as well as a whistleblower policy and an anti-bribery and corruption policy. Additionally, the company has a combined Audit and Risk Management Committee and a Remuneration Committee, both with charters and disclosed membership details.
The company has disclosed a process for evaluating the performance of senior executives and has provided a board skills matrix. It has also disclosed the names of independent directors and their length of service, and has a continuous disclosure compliance policy. Information about the company and its governance is available on the company website.
Pro Medicus Limited has disclosed an investor relations program and how it facilitates and encourages participation at meetings of security holders.
These disclosures are part of the company’s adherence to various corporate governance principles and recommendations set by the ASX Corporate Governance Council.